Purchase Order 36C25923P1203

Award Date 7/3/23
Potential Completion Date 7/3/23
Potential Value Not listed
Ultimate Awardee
Abbvie Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of breast implants to the Veterans Integrated Service Network 2 (VISN 2), which is part of the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The prime contractor is Allergan, Inc., a for-profit manufacturer of medical devices and healthcare products. The contract is a firm-fixed-price purchase order with a ceiling value of $14,187. It does not have a set-aside designation. The contract has an ultimate completion date of...
This federal contract award to Allergan USA Inc., a subsidiary of AbbVie Inc., is for the procurement of breast implants. The $14,124.00 fixed-price purchase order was issued by the Veterans Integrated Service Network 2, a component of the Department of Veterans Affairs. The contract has no set-aside designation, indicating Allergan USA Inc. is the sole-source provider for these specialized medical devices. The award is associated with multiple Indefinite Delivery/Indefinite Quantity (IDV)...
The U.S. Department of Veterans Affairs (VA) awarded a $36,934.29 firm fixed-price purchase order contract to Allergan, Inc. for the provision of medical implants. The award was made on December 5, 2024 without any set-aside designation. The contract has a period of performance through December 31, 2024. Allergan, Inc. is a for-profit medical device manufacturer that specializes in surgical implants, prosthetics, and related products. As a subsidiary of the parent company AbbVie Inc., Allergan...
This firm-fixed-price purchase order was awarded by the Veterans Integrated Service Network 22, a civilian agency of the Department of Veterans Affairs, to Allergan USA Inc., a subsidiary of AbbVie Inc. The $21,045 contract is for the supply of prosthetics and surgical implants, specifically breast reconstruction products, to support medical procedures for the VA's patient population. Allergan is a leading provider of these specialized medical devices to various federal agencies, including the...
This purchase order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awards Allergan USA Inc. $28,374 to supply prosthetic implant items with no set-aside designation. As a subsidiary of Abbvie Inc., Allergan will deliver the ordered devices to support reconstructive procedures at the specified location in Irvine, California by the established completion date of March 13, 2024. Allergan routinely provides specialty medical devices...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Allergan USA Inc., a subsidiary of Abbvie Inc. The $23,645.00 contract is for the delivery of prosthetic implant items to support reconstructive procedures at VA medical facilities. As a sole-source provider of proprietary medical devices, Allergan has supplied breast implants, tissue expanders, and other specialty components to the Department of Defense and Department of...
This federal contract award is for the delivery of medical implants to the Veterans Integrated Service Network 5 (VISN 5), a component of the U.S. Department of Veterans Affairs (VA). The prime contractor is Allergan USA Inc., a subsidiary of AbbVie Inc., a leading provider of medical devices and pharmaceutical products to various federal agencies, including the VA and Department of Defense (DoD). The contract has a firm-fixed price of $15,934.00 and a completion date of July 24, 2024. It is a...
This $35,788 federal contract award with Allergan, Inc., a subsidiary of AbbVie Inc., is for the supply of medical implants to the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN). The contract, awarded on February 11, 2025, is structured as a firm fixed-price purchase order with a completion date of March 31, 2025. Allergan, a for-profit medical device manufacturer, has a long-standing history of providing specialized surgical components and prosthetic devices to...
This firm fixed-price purchase order was awarded to Abbvie US LLC, a subsidiary of global biopharmaceutical company Abbvie Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The $47,085.17 contract is for the supply of surgical breast implants, with a period of performance through January 27, 2025. The award is not set aside and represents one of several federal contracts and indefinite delivery/indefinite quantity vehicles held by Abbvie US LLC to provide...
This federal contract award, valued at $29,604, was issued by the Veterans Integrated Service Network 2 (VISN 2) to Allergan USA Inc., a subsidiary of AbbVie Inc. The contract is for the delivery of medical implants, specifically breast implants and tissue expanders, which are used in reconstructive and aesthetic procedures. Allergan USA Inc. is a prominent supplier of medical devices and pharmaceutical products to various federal agencies, including the Department of Defense, Department of...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a $12,717.30 firm fixed price purchase order to Allergan USA Inc., a division of Abbvie Inc., to provide breast implants. The contract has a period of performance from July 3, 2023 through September 3, 2023, with work taking place in Irvine, California. Under this award, Allergan will deliver breast implant products to support the VA's provision of healthcare services to veterans. As the prime contractor on this contract, Allergan is responsible for fulfilling the agency's requirements for these medical devices during the specified period.

Generated 12/24/23, 1:54 PM